GLRE

GLRE is a rare case where quality and cheapness overlap. FY2025 net income jumped 74.8% to $74.8M ($2.17 diluted EPS, +75%), driven by a genuine underwriting turnaround — net underwriting income of $35.7M versus a $8.2M loss the prior year, with gross premiums written up 10.7%. Critically, the MD&A confirms A.M. Best upgraded the rating to A (Excellent), which management says opened 'greater opportunities' at the January 2026 renewals thanks to a stronger balance sheet. That balance sheet is fortress-like: long-term debt was cut 92.2% to just $4.72M against $708M of equity, cash surged 72.8% to $112M, and operating cash flow rose 88.5% to $210M. Fully diluted book value per share is $20.43, up 13.8%.

The valuation is the whole argument. At $16.37 the stock trades at 0.80x book value and 7.5x earnings — the market is pricing GLRE as if the underwriting improvement is temporary and equity is worth less than stated. Management is voting with cash, repurchasing $9.82M of shares (up 31.2%) below book, which is accretive. A 10.6% ROE on a company bought at a 20% discount to book implies a materially higher return on the purchase price, and any re-rating toward book — supported by the ratings upgrade and improved underwriting — is the upside.